GL1X · GenesisL1 explorer

Research workbench

Solution structure of an isolated antibody vl domain

Analyse Solution structure of an isolated antibody vl domain in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1MAK
Type
protein
Length
113 residues
Chains
1
Method
solution nmr
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
IGG2A-kappa 26-10 fv (light chain)
UniProt
P01631
Pockets
1 · best druggability 0.30

Structure

solution nmr · 1 distinct chain · 0% helix, 43% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AIGG2A-kappa 26-10 fv (light chain)protein1130% helix, 43% strandP01631

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1540.300.7617empty

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 1MAK · Solution structure of an isolated antibody vl domain · the same entry in another collection · chain A against A, TM-score 1.00
  • P01631 · AlphaFold monomer V2.0 prediction for ig kappa chain V-II region 26-10 (P01631) · a predicted model of the same protein · chain A against A, TM-score 0.93

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.